Michael O'Connor, Ph.D., is a professor of radiologic physics at the Mayo Clinic in Rochester, Minn.


July 29, 2009 - Doctors at the Mayo Clinic in Rochester, Minn., have developed a "molecular imaging" technique for detecting cancer in dense breast tissue using radioactive tracers.
Presenting at the APPM 51st Annual Meeting in Anaheim, Calif., on July 28, 2009, Michael O'Connor, Ph.D., a professor of radiologic physics at Mayo, described the science behind this technique as well as the latest results from ongoing clinical trials, including one involving 1,000 women who all received the molecular imaging.

In the talk, "Molecular Imaging of the Breast," O'Connor explained how the technique has shown to be highly sensitive at detecting breast cancer. The key now is to make sure that the doses administered are as low as possible - equivalent to what you would receive in a mammogram. A study supported by the Susan G. Komen Foundation will begin enrolling 1,000 women in a few months to see how effective the technique is with low-dose formulations.

For more information: http://www.aapm.org/meetings/09AM/PRAbs.asp?mid=42&aid=11931


Related Content

News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | PET Imaging

May 29, 2026 — GE HealthCare recently announced that its MIM KineticID modeling software1 is now 510(k) pending with the ...

Time May 29, 2026
arrow
News

May 21, 2026 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 22, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
News | Women's Health

May 6, 2026 — GE HealthCare has announced the availability of MIM ComboTherapy GYN HDR/EBRT2, a solution designed to ...

Time May 06, 2026
arrow
News | Breast Imaging

April 15, 2026 — QT Imaging Holdings, Inc. has launched its QTI Imaging-Olea Viewer, developed in collaboration with ...

Time April 15, 2026
arrow
News | SNMMI

The Society of Nuclear Medicine and Molecular Imaging's (SNMMI) 2026 Annual Meeting will take place May 30–June 2 in Los ...

Time April 07, 2026
arrow
Subscribe Now